Alnylam Pharmaceuticals: RNA Interference Holds Promise For Cholesterol-Lowering Drugs

New York Times -- People whose bodies make an unusually active form of a certain protein tend to have dangerously high levels of cholesterol. Those with an inactive form of the protein have low cholesterol and a low risk of heart attacks.

MORE ON THIS TOPIC